+1 (704) 266-3234

Global Herpes Labialis (Oral Herpes) Drugs Market Research 2011- 2022

Published on: May 2017 | From USD $2290 | Published By: HEYREPORTS | Number Of Pages: 87

Summary
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
The Global Herpes Labialis (Oral Herpes) Drugs market is estimated to reach 2 Billion USD in 2017. On the basis of region, North America is the largest market segment of Herpes Labialis (Oral Herpes) Drugs, followed by Europe and Asia. In the report, HeyReport says External Use dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
By Type
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
North America
Europe
Asia
South America
Based on Application, the report describes major Application share of regional market. Application mentioned as follows:
External Use
Oral
Injection
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Aciclovir
1.2.1.2 Valacyclovir
1.2.1.3 Famciclovir
1.2.1.4 Docosanol
1.2.2 by Application
1.2.2.1 External Use
1.2.2.2 Oral
1.2.2.3 Injection
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Global Aciclovir Market, 2011-2016
4.1.2 Global Valacyclovir Market, 2011-2016
4.1.3 Global Famciclovir Market, 2011-2016
4.1.4 Global Docosanol Market, 2011-2016
4.2 Market Forecast
4.2.1 Global Aciclovir Market Forecast, 2017-2022
4.2.2 Global Valacyclovir Market Forecast, 2017-2022
4.2.3 Global Famciclovir Market Forecast, 2017-2022
4.2.4 Global Docosanol Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Global External Use Market, 2011-2016
5.1.2 Global Oral Market, 2011-2016
5.1.3 Global Injection Market, 2011-2016
5.2 Market Forecast
5.2.1 Global External Use Market Forecast, 2017-2022
5.2.2 Global Oral Market Forecast, 2017-2022
5.2.3 Global Injection Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market by Region
6.1.1 North America
6.1.1.1 North America Herpes Labialis (Oral Herpes) Drugs Market, 2011-2016
6.1.1.2 North America Herpes Labialis (Oral Herpes) Drugs Market by Type
6.1.1.3 North America Herpes Labialis (Oral Herpes) Drugs Market by Application
6.1.2 Europe
6.1.2.1 Europe Herpes Labialis (Oral Herpes) Drugs Market, 2011-2016
6.1.2.2 Europe Herpes Labialis (Oral Herpes) Drugs Market by Type
6.1.2.3 Europe Herpes Labialis (Oral Herpes) Drugs Market by Application
6.1.3 Asia
6.1.3.1 Asia Herpes Labialis (Oral Herpes) Drugs Market, 2011-2016
6.1.3.2 Asia Herpes Labialis (Oral Herpes) Drugs Market by Type
6.1.3.3 Asia Herpes Labialis (Oral Herpes) Drugs Market by Application
6.1.4 South America
6.1.4.1 South America Herpes Labialis (Oral Herpes) Drugs Market, 2011-2016
6.1.4.2 South America Herpes Labialis (Oral Herpes) Drugs Market by Type
6.1.4.3 South America Herpes Labialis (Oral Herpes) Drugs Market by Application
6.2 Market Forecast
6.2.1 North America Market Forecast, 2017-2022
6.2.2 Europe Market Forecast, 2017-2022
6.2.3 Asia Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Herpes Labialis (Oral Herpes) Drugs Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 GSK
8.1.1 Profile
8.1.2 Business Performance
8.2 Novartis
8.2.1 Profile
8.2.2 Business Performance
8.3 Teva
8.3.1 Profile
8.3.2 Business Performance
8.4 Mylan
8.4.1 Profile
8.4.2 Business Performance
8.5 Cadila
8.5.1 Profile
8.5.2 Business Performance
8.6 Apotex
8.6.1 Profile
8.6.2 Business Performance
8.7 Daewoong Pharmaceutical
8.7.1 Profile
8.7.2 Business Performance
8.8 Livzon
8.8.1 Profile
8.8.2 Business Performance
8.9 Luoxin
8.9.1 Profile
8.9.2 Business Performance
8.10 Med shine
8.10.1 Profile
8.10.2 Business Performance
8.11 Bayer (Campho Phenique)
8.12 Blistex
8.13 Kelun Group
8.14 Hikma
8.15 Haiwang
8.16 Carmex
8.17 Cipher
9 Conclusion

Table Product Specifications of Herpes Labialis (Oral Herpes) Drugs
Table Products Segment of Herpes Labialis (Oral Herpes) Drugs
Table Aciclovir Overview
Table Valacyclovir Overview
Table Famciclovir Overview
Table Docosanol Overview
Table Global Herpes Labialis (Oral Herpes) Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Herpes Labialis (Oral Herpes) Drugs
Table External Use Overview
Table Oral Overview
Table Injection Overview
Table Global Herpes Labialis (Oral Herpes) Drugs Market by Application, 2011-2022 (USD Million)
Table Global Herpes Labialis (Oral Herpes) Drugs Market by Region, 2011-2022 (USD Million)
Table Market Dynamics
Table Policy of Herpes Labialis (Oral Herpes) Drugs
Table Herpes Labialis (Oral Herpes) Drugs Market of Global by Vendors, 2011-2016 (USD Million)
Table Price Factors List
Table GSK Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of GSK(USD Million)
Table Novartis Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Novartis(USD Million)
Table Teva Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Teva(USD Million)
Table Mylan Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Mylan(USD Million)
Table Cadila Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Cadila(USD Million)
Table Apotex Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Apotex(USD Million)
Table Daewoong Pharmaceutical Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Daewoong Pharmaceutical(USD Million)
Table Livzon Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Livzon(USD Million)
Table Luoxin Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Luoxin(USD Million)
Table Med shine Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Med shine(USD Million)
Table Bayer (Campho Phenique) Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Bayer (Campho Phenique)(USD Million)
Table Blistex Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Blistex(USD Million)
Table Kelun Group Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Kelun Group(USD Million)
Table Hikma Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Hikma(USD Million)
Table Haiwang Profile List
Table Herpes Labialis (Oral Herpes) Drugs Operating Data of Haiwang(USD Million)
Figure Herpes Labialis (Oral Herpes) Drugs Picture
Figure Industry Chain Structure of Herpes Labialis (Oral Herpes) Drugs
Figure SWOT of Herpes Labialis (Oral Herpes) Drugs
Figure GDP of Major Countries
Figure Aciclovir Market Size and Growth, 2011-2016 (USD Million)
Figure Valacyclovir Market Size and Growth, 2011-2016 (USD Million)
Figure Famciclovir Market Size and Growth, 2011-2016 (USD Million)
Figure Docosanol Market Size and Growth, 2011-2016 (USD Million)
Figure Aciclovir Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Valacyclovir Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Famciclovir Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Docosanol Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure External Use Market Size and Growth, 2011-2016 (USD Million)
Figure Oral Market Size and Growth, 2011-2016 (USD Million)
Figure Injection Market Size and Growth, 2011-2016 (USD Million)
Figure External Use Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Oral Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Injection Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size by Type, 2016 (USD Million)
Figure North America Market Share by Type, 2016 (USD Million)
Figure North America Market Size by Application, 2016 (USD Million)
Figure North America Market Share by Application, 2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size by Type, 2016 (USD Million)
Figure Europe Market Share by Type, 2016 (USD Million)
Figure Europe Market Size by Application, 2016 (USD Million)
Figure Europe Market Share by Application, 2016 (USD Million)
Figure Asia Market Size and Growth, 2011-2016 (USD Million)
Figure Asia Market Size by Type, 2016 (USD Million)
Figure Asia Market Share by Type, 2016 (USD Million)
Figure Asia Market Size by Application, 2016 (USD Million)
Figure Asia Market Share by Application, 2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size by Type, 2016 (USD Million)
Figure South America Market Share by Type, 2016 (USD Million)
Figure South America Market Size by Application, 2016 (USD Million)
Figure South America Market Share by Application, 2016 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Herpes Labialis (Oral Herpes) Drugs Market Share of Global by Vendors, 2016 (USD Million)
Figure Herpes Labialis (Oral Herpes) Drugs Market Concentration
Figure Marketing Channels Overview

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2290
USD $2750
USD $3580

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.